PubMed · 2010 · 64 citations · 16 references
MedicineMolecular BiologyOncologyBreast OncologyChemotherapyMolecular OncologyCancer Cell SignalingCancer ProgressionMalignant NeoplasmsMitotic InhibitorsTargeted Cancer TherapyTumor Suppressor GenesApoptosis TargetingBreast Cancer ChemotherapyBreast Cancer Resistance MechanismsCancer Cell Proliferation InhibitionRadiation Resistance MechanismsSurvivin Inhibition
Survivin is a cancer gene that is silenced in differentiated tissues, while overexpressed at high levels in vast majority of tumors. It has garnered great interests in recent years. Some essential properties characterizing it as an ideal target involve inhibiting apoptosis, promoting mitosis, stimulating vessel growth thus inducing chemo-resistance. These functions touch the full gamut of tumorigenesis, including proliferation, migration, and invasion, and collectively facilitate malignant behavior. In the case of breast cancer, survivin detection independent or combined in serum and/or urine has emerged as a measure for diagnosis. Moreover, many studies indicated aberrant expression of survivin is associated with poor prognosis and drug/radiation resistance. Strategies targeting survivin to treat breast cancer have got promising initial results. In this review, we summarize its role in breast cancer's diagnosis, prognosis, and treatment, with the intention to explain why this interesting molecule plays a conflicting role.
16
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Bharat B. Aggarwal, Anjana Bhardwaj, Rishi S. Aggarwal et al. · PubMed · 2004 · 1.4K citations
Medicine, Oncology, Pharmacology +13
Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.
Keitaro Tanaka, Goki Gon, Takehiro Nohara et al. · PubMed · 2000 · 336 citations
Medicine, Cancer Biology, Oncology +14
Regulation of microtubule stability and mitotic progression by survivin.
Alessandra Giodini, Marko J. Kallio, Nathan R. Wall et al. · PubMed · 2002 · 257 citations
Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Nathan R. Wall, Daniel O’Connor, Janet Plescia et al. · PubMed · 2003 · 253 citations · Full text
Medicine, Cancer Biology, Oncology +17